lightbulb brain graphic
T32 Training Program

Supporting graduate students and postdoctoral fellows in addiction science for over 25 years

Translational Explorations in Substance Use DisordersT32 Training Program

Substance use disorders (SUDs) constitute a major, high-impact health problem in the United States. Our T32 training program has contributed great insight into the mechanisms and etiology of SUDs and the future for precision medicine to optimize SUD therapies.


The goal of our T32 renewal is to equip scholars with a maximally integrated toolbox and innovative mindset to optimize the scientific understanding of SUDs and translate toward effective solutions.

Our faculty mentors/co-mentors have a wealth of training and career development successes, extensive collaborative networks, and expertise in translational addiction research conducted with modern technologies. T32 tactics include well-funded, state-of-the-art research opportunities and facilities, effective mentoring plans (mentor mosaics), internships/externships, and supportive interactive programs.

Our first-rate activities also focus on the professional skills needed for advancement towards an independent SUD-directed career, including dissemination of our learnings though peer-reviewed publications and community venues to improve public health, productivity, and life fulfillment.


T32 Objectives

Contact Us

Center for Addiction Sciences and Therapeutics
Phone: (409) 772-3093
Mailing address:
301 University Boulevard
Galveston, TX 77555-0615

Program Interests & Priorities

Discovery of mechanisms underlying SUD processes (“cell to human”)

SUD Mechanisms, Neurocircuitry, NeuroID. Exploit state-of-the-art tools to uncover molecular and biological mechanisms involving cell-surface proteins and transcriptomic factors, neurocircuitry engaged in behavioral facets of SUDs, biological impacts of exposure to abused drugs, and phenotypic and genotypic drivers of behavior in SUDs.

Mechanistic knowledge to drive new perspectives for SUD therapeutics

Chemistry, Drug Discovery, SUD Therapeutics. Capitalize on our enhanced understanding of key cellular and molecular mechanisms underlying SUDs and to selectively normalize impaired brain mechanisms that contribute to continued drug use in SUDs.

Translation of SUD sciences into evidence-based clinical, population and public health strategies

Pharmacological Challenges, Brain and Behavioral Health, Data Science, Health Analytics. Explore genetics, development, and social factors that contribute to SUD and integrate into clinical practice and public health.

Participating Graduate Programs

Biochemistry, Cellular and Molecular Biology • Experimental Pathology • Human Pathophysiology and Translational Medicine • Neuroscience • Pharmacology and Toxicology • Population Health Sciences

Training Program Faculty

NameTitlePrimary Dept or ProgramResearch Interest
John A. Allen, PhDAssistant ProfessorPHTOGPCRs, SUDs, and therapeutics discovery
Noelle C. Anastasio, PhDAssociate ProfessorPHTOGlu in impulsivity, SUDs, and therapeutics discovery
Irma E. Cisneros, PhDAssistant ProfessorPATHNeuroinflammation in SUDs
Kathryn A. Cunningham, PhDProfessor & Director, CASTPHTOSUD risk vulnerability mechanisms, circuitry and therapeutics discovery
Eliseo A. Eugenin, PhDProfessorNeurobiologyNeuroAIDS and substance use
Benjamin B. GelmanProfessorPATHNeuroAIDS and substance use
Georgiy Golovko, PhDAssistant ProfessorPHTOBioinformatics, computational, Health analytics
Thomas A. GreenAssociate ProfessorPHTOEnvironmental enrichment and frustration in drug abuse
Jonathan D. Hommel, PhDAssociate ProfessorPHTOMechanisms of SUDs, obesity, compulsivity
David C. Houghton, PhDAssistant ProfessorPSYCHSUDs, opioids, chronic pain, compulsivity
Yong-Fang Kuo, PhDProfessorSPPHEpidemiology, prediction models, opioid substitutes
Fernanda Laezza, MD, PhDProfessorPHTOIon channels as drug discovery targets in SUDs
Agenor Limon, DSCAssistant ProfessorNeurologyNeuronal excitation-inhibition imbalance
Monique R. Pappadis, PhDAssociate ProfessofSPPHMinority health disparities in rehabilitation
Gabrielle R. Rudenko, PhDProfessorPHTOSynaptic mechanisms and SUD target discovery
Heido Spratt, PhDAssociate ProfessorSPPHBiostatistics, bioinformatics, machine learning
Gracie Vargas, PhDProfessorNeurobiologyNeurocircuitry imaging in obesity and SUDs
Denise M. Wilkes, MD, PhDProfessorANESTHOpioid prescription compliance devices/medical treatments
Ping Wu, PhDProfessorNeurobiologySUDs and neural stem cells
Jia Zhou, PhDProfessorPHTOMedicinal chemistry and drug discovery for SUDs

Eligibility and Nomination

Submit all documentation as a single PDF (in order listed above) to Questions? Please contact us at 409-772-3093

Eligibility Criteria

  1. U.S. Citizenship or permanent residency
  2. Predoctoral candidates must be enrolled in a UTMB graduate program and should have completed required first-year coursework
  3. Evidence of academic and research excellence, creativity, and motivation (including strong transcripts and research productivity)
  4. Proposed research project relevant to thematic interests of the training program
  5. Long-term dedication to advancing the science of SUDs

Nomination Requirements

  1. Candidate should identify a primary Faculty Mentor and a Co-Mentor
  2. Single LETTER OF NOMINATION co-signed by Faculty Mentor and Co-Mentor which addresses the nominee’s education, background and productivity, progress in graduate program to date, proposed research project, potential for project success, and commitment to a career that advances the science of SUDs (one page maximum)
  3. Nominee’s current CURRICULUM VITAE
  4. Mentor and Co-Mentor’s current CURRICULUM VITAE

Last Updated: March 12, 2024 RMG